You are here: Industry Insights > Fosun

News List

BioNTech’s 2Q Revenue Soars contractpharma
August 10, 2021
Growth due to rapid increases in the supply of BNT162b2 as BioNTech and Pfizer evaluate a third dose to boost efficacy against Delta variant.
China's first CAR-T Cell Therapy approved-Fosun Kite Axicabtagene Ciloleucel (FKC876) prnasia
June 25, 2021
On June 23, 2021, Fosun Kite Biotechnology announced its autologous CD19-directed CAR-T cell therapy Axicabtagene Ciloleucel (FKC876) (axicabtagene ciloleucel) has been approved by China National Medical Products Administration (NMPA) for the ...
China and India Combat Coronavirus Pandemic Together: Online Ceremony Held for the Handover of Medical Supplies to Aid India prnasia
June 21, 2021
On 11 June 2021, an online ceremony was held for the handover of anti-pandemic supplies to aid India. Medical supplies to India included 135 oxygen concentrators, 5 ventilators and 3,300 KN95 masks.
BioNTech and Fosun Pharma Receive Authorization for Emergency Use in Hong Kong, S.A.R., China for COVID-19 Vaccine prnewswire
January 26, 2021
BioNTech SE and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. announced that according to the Food and Health Bureau of the Hong Kong, S.A.R., China Special Administrative Region of the PRC, the COVID-19 vaccine COMIRNATY® (also known as BNT162b2, Chine
BioNTech and Fosun to supply 100 million Covid-19 vaccine doses to China pharmaceutical-technology
December 18, 2020
German company BioNTech and Shanghai Fosun Pharmaceutical (Fosun Pharma) have entered into an agreement to supply initially 100 million doses of mRNA-based Covid-19 vaccine candidate, BNT162, to Mainland China next year.
From China to the World, Fosun's Fight against COVID-19 Continues prnasia
April 07, 2020
At 7:00 pm Beijing time on April 6, Fosun hosted a global virtual conference on fighting against COVID-19 on the 39th floor of Fosun's headquarters - the Bund Finance Center in Shanghai.
BioNTech signs Covid-19 vaccine deals with Pfizer and Fosun pharmaceutical-technology
March 18, 2020
German biotechnology firm BioNTech has partnered with Pfizer to jointly develop and distribute a potential mRNA-based Covid-19 vaccine.
VolitionRx commences lung cancer clinical study with Fosun in China biospectrumasia
July 22, 2019
Belgium based VolitionRx Limited has executed a contract under the previously announced Memorandum of Understanding, with Shanghai Fosun Long March Medical Science Co., Ltd. to help introduce the Nu.Q(TM) platform to China.
Fosun Launches Fourth Edition of Its Acceleration Program "Protechting" prnasia
July 05, 2019
Fosun and its portfolio companies Fidelidade, Luz Saude and Hauck & Aufhauser launched the fourth edition of the startups acceleration program - Protechting - which aims to ...
Fosun to showcase its global healthcare developments in CIIE biospectrumasia
November 07, 2018
Fosun's 11 portfolio companies and business partners in overseas healthcare sector will attend the expo and showcase Fosun's latest development in the global health in

Previous page 1 2 3 Next page